Wei Wei

7.8k total citations · 2 hit papers
243 papers, 5.2k citations indexed

About

Wei Wei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wei Wei has authored 243 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 77 papers in Pulmonary and Respiratory Medicine and 64 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wei Wei's work include Breast Cancer Treatment Studies (40 papers), MRI in cancer diagnosis (35 papers) and Breast Lesions and Carcinomas (26 papers). Wei Wei is often cited by papers focused on Breast Cancer Treatment Studies (40 papers), MRI in cancer diagnosis (35 papers) and Breast Lesions and Carcinomas (26 papers). Wei Wei collaborates with scholars based in United States, China and United Kingdom. Wei Wei's co-authors include James L. Abbruzzese, Sarah Taylor, Kenneth R. Hess, Gauri R. Varadhachary, Martin N. Raber, Renato Lenzi, Vikas Kundra, Brian P. Hobbs, Cher Heng Tan and Chaan S. Ng and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Wei

230 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metastatic patterns in adenocarcinoma

2006 636 citations Wei Wei et al. profile →
Systematic analysis of telomere length and somatic alterations in 31 cancer types

2017 416 citations Wei Wei, Siyuan Zheng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Wei United States	32	1.8k	1.5k	1.1k	902	900	243	5.2k
Kan Yonemori Japan	38	3.8k 2.1×	1.9k 1.3×	1.0k 0.9×	1.4k 1.5×	898 1.0×	392	6.2k
Roy H. Decker United States	39	2.0k 1.1×	2.6k 1.7×	915 0.8×	780 0.9×	557 0.6×	175	4.9k
Shin‐Cheh Chen Taiwan	35	2.9k 1.6×	1.8k 1.2×	583 0.5×	666 0.7×	1.3k 1.5×	128	4.9k
A. Dimitrios Colevas United States	51	3.4k 1.9×	2.1k 1.4×	815 0.7×	1.6k 1.8×	582 0.6×	197	7.6k
George Pentheroudakis Greece	43	4.5k 2.5×	1.5k 1.0×	602 0.5×	1.6k 1.7×	1.3k 1.5×	228	7.6k
Bin S. Teh United States	48	2.0k 1.1×	4.0k 2.6×	1.6k 1.4×	1.2k 1.4×	1.1k 1.2×	374	8.4k
Ariane Dunant France	35	3.1k 1.7×	3.7k 2.4×	643 0.6×	1.3k 1.4×	1.3k 1.5×	82	8.5k
Franco Nolè Italy	37	3.3k 1.8×	1.5k 1.0×	595 0.5×	693 0.8×	1.9k 2.2×	176	5.1k
Gloria Broadwater United States	42	3.1k 1.7×	1.0k 0.7×	656 0.6×	1.2k 1.3×	1.8k 2.0×	182	6.2k
Steve R. Martinez United States	36	1.3k 0.7×	943 0.6×	331 0.3×	669 0.7×	725 0.8×	92	3.1k

Countries citing papers authored by Wei Wei

Since Specialization

Citations

This map shows the geographic impact of Wei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wei more than expected).

Fields of papers citing papers by Wei Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wei. The network helps show where Wei Wei may publish in the future.

Co-authorship network of co-authors of Wei Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wei. A scholar is included among the top collaborators of Wei Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wei. Wei Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhatia, Aarti, Ranee Mehra, Jessica R. Bauman, et al.. (2025). Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Head & Neck. 47(9). 2373–2382. 2 indexed citations

Wei, Wei, Meriel P Burns, Deepa Jagadeesh, et al.. (2025). Assessment of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplant When Comparing Treatment with and without Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy. 31(2). S372–S372. 1 indexed citations

Yu, Jennifer S., Ran Zhao, Wei Wei, et al.. (2025). Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastoma. Neuro-Oncology Advances. 7(1). vdaf038–vdaf038. 2 indexed citations

Johnson, Justin M., Halle C. F. Moore, Megan Kruse, et al.. (2024). Abstract PO2-17-12: Phase I Trial of alpha-lactalbumin vaccine in high risk operable triple negative breast cancer (TNBC) and patients at high genetic risk for TNBC. Cancer Research. 84(9_Supplement). PO2–17. 1 indexed citations

Wei, Wei, et al.. (2024). Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Prognostic Nutritional Index as Prognostic Markers for Lung Carcinoma. British Journal of Hospital Medicine. 85(10). 1–13. 5 indexed citations

Aleixo, Gabriel, Stephanie A. Valente, Wei Wei, & Halle C. F. Moore. (2023). Association of body composition and surgical outcomes in patients with early-stage breast cancer. Breast Cancer Research and Treatment. 202(2). 305–311. 4 indexed citations

Aleixo, Gabriel, Wei Wei, Po‐Hao Chen, et al.. (2023). The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma. Bone Marrow Transplantation. 58(12). 1384–1389. 2 indexed citations

Nizam, Amanda, Ryan K. Rader, Alice Tzeng, et al.. (2023). Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events. Clinical Genitourinary Cancer. 22(2). 368–379. 6 indexed citations

Brown, Landon C., Kunal Desai, Wei Wei, et al.. (2021). Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab. Journal for ImmunoTherapy of Cancer. 9(9). e003281–e003281. 13 indexed citations

10.

Kruse, Megan, Mona Patel, Jeffrey M. McManus, et al.. (2021). Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer. JCI Insight. 6(20). 15 indexed citations

11.

Swaidani, Shadi, Ann S. Kim, Bicky Thapa, et al.. (2021). Increased incidence of venous thromboembolism with cancer immunotherapy. Med. 2(4). 423–434.e3. 84 indexed citations

12.

Hori, Yusuke S., Krishna C. Joshi, Wei Wei, et al.. (2020). RADT-01. THE EFFICACY AND SAFETY OF TWO-STAGED STEREOTACTIC RADIOSURGERY FOR LARGE POSTERIOR FOSSA METASTASES: POST-TREATMENT VOLUMETRIC CHANGES IN TUMOR SIZE, PERI-TUMORAL EDEMA, AND FOURTH VENTRICLE. Neuro-Oncology. 22(Supplement_2). ii181–ii181. 3 indexed citations

13.

Debnam, J. Matthew, Nandita Guha‐Thakurta, Jia Sun, et al.. (2020). Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT. American Journal of Neuroradiology. 41(5). 844–851. 5 indexed citations

14.

Fallah, Jaleh, C. Marcela Díaz‐Montero, Patricia Rayman, et al.. (2020). Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival. Clinical Genitourinary Cancer. 18(6). 500–508. 8 indexed citations

15.

Zheng, Siyuan, Kristin Alfaro-Munoz, Wei Wei, et al.. (2019). Prospective Clinical Sequencing of Adult Glioma. Molecular Cancer Therapeutics. 18(5). 991–1000. 15 indexed citations

16.

Tannenbaum, Charles S., Patricia Rayman, Paul G. Pavicic, et al.. (2019). Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs. Cancer Immunology Research. 7(10). 1687–1699. 39 indexed citations

17.

Vu, Thinh, Dawid Schellingerhout, Nandita Guha‐Thakurta, et al.. (2018). Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT. American Journal of Neuroradiology. 40(1). 142–149. 20 indexed citations

18.

Lei, Dong, et al.. (2014). Changes of characteristics of neural stem cells in a neonatal rat modelwith hypoxic-ischemic encephalopathy.. Biomedical Research-tokyo. 25(4). 0. 1 indexed citations

19.

Zhang, Jie, Kentaro Iwanaga, Kuicheon Choi, et al.. (2008). Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR -Mutant Cells. Cancer Prevention Research. 1(3). 201–207. 59 indexed citations

20.

Wei, Wei. (1966). SOME OBSERVATIONS ON THE PRODUCTION OF RICKETTSIAL INTERFERON FROM MOUSE LUNG. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact